世界のオンダンセトロン塩酸塩産業:成長傾向・競合分析2019-2025

QYResearchが発行した調査報告書(QYR20FB06015)
◆英語タイトル:Global Ondansetron Hydrochloride Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:QYR20FB06015
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月5日(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のオンダンセトロン塩酸塩市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。オンダンセトロン塩酸塩の種類別には、純度≥97%、純度≥98%、純度≥99%に、用途別には、オンダンセトロン塩酸塩注射液、オンダンセトロン塩酸塩経口カプセルに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・オンダンセトロン塩酸塩の種類別市場規模:純度≥97%、純度≥98%、純度≥99%
・オンダンセトロン塩酸塩の用途別市場規模:オンダンセトロン塩酸塩注射液、オンダンセトロン塩酸塩経口カプセル
・オンダンセトロン塩酸塩の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Inke APIs、Beaukev、Cadila Pharmaceutical、Cambrex、Dr. Reddy’s、Tapi Teva、SMS Pharmaceuticals、Smaart Pharmaceutical、Changzhou Kangyun Jingxi Chemical、Sinopharm Chuankang Pharmaceutical、Qilu Pharmaceutical
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

It has a white powder appearance and is used as an antiemetic agent. CAS number is 99614-01-4.The Ondansetron Hydrochloride market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ondansetron Hydrochloride.

This study focuses on the production side and consumption side of Ondansetron Hydrochloride, presents the global Ondansetron Hydrochloride market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Ondansetron Hydrochloride capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Ondansetron Hydrochloride by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Inke APIs
Beaukev
Cadila Pharmaceutical
Cambrex
Dr. Reddy’s
Tapi Teva
SMS Pharmaceuticals
Smaart Pharmaceutical
Changzhou Kangyun Jingxi Chemical
Sinopharm Chuankang Pharmaceutical
Qilu Pharmaceutical

Market Segment by Product Type
Purity≥97%
Purity≥98%
Purity≥99%

Market Segment by Application
Ondansetron Hydrochloride Injection
Ondansetron Hydrochloride Oral Capsule

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Ondansetron Hydrochloride status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Ondansetron Hydrochloride manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ondansetron Hydrochloride are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Ondansetron Hydrochloride Market Size Growth Rate by Type
1.3.2 Purity≥97%
1.3.3 Purity≥98%
1.3.4 Purity≥99%
1.4 Market Segment by Application
1.4.1 Global Ondansetron Hydrochloride Market Share by Application (2019-2025)
1.4.2 Ondansetron Hydrochloride Injection
1.4.3 Ondansetron Hydrochloride Oral Capsule
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Ondansetron Hydrochloride Production Value 2014-2025
2.1.2 Global Ondansetron Hydrochloride Production 2014-2025
2.1.3 Global Ondansetron Hydrochloride Capacity 2014-2025
2.1.4 Global Ondansetron Hydrochloride Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Ondansetron Hydrochloride Market Size CAGR of Key Regions
2.2.2 Global Ondansetron Hydrochloride Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Ondansetron Hydrochloride Capacity by Manufacturers
3.1.2 Global Ondansetron Hydrochloride Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Ondansetron Hydrochloride Revenue by Manufacturers (2014-2019)
3.2.2 Ondansetron Hydrochloride Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Ondansetron Hydrochloride Market Concentration Ratio (CR5 and HHI)
3.3 Ondansetron Hydrochloride Price by Manufacturers
3.4 Key Manufacturers Ondansetron Hydrochloride Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Ondansetron Hydrochloride Market
3.6 Key Manufacturers Ondansetron Hydrochloride Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Purity≥97% Production and Production Value (2014-2019)
4.1.2 Purity≥98% Production and Production Value (2014-2019)
4.1.3 Purity≥99% Production and Production Value (2014-2019)
4.2 Global Ondansetron Hydrochloride Production Market Share by Type
4.3 Global Ondansetron Hydrochloride Production Value Market Share by Type
4.4 Ondansetron Hydrochloride Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Ondansetron Hydrochloride Consumption by Application

6 Production by Regions
6.1 Global Ondansetron Hydrochloride Production (History Data) by Regions 2014-2019
6.2 Global Ondansetron Hydrochloride Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaOndansetron Hydrochloride Production Growth Rate 2014-2019
6.3.2 North America Ondansetron Hydrochloride Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Ondansetron Hydrochloride Import & Export
6.4 Europe
6.4.1 Europe Ondansetron Hydrochloride Production Growth Rate 2014-2019
6.4.2 Europe Ondansetron Hydrochloride Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Ondansetron Hydrochloride Import & Export
6.5 China
6.5.1 China Ondansetron Hydrochloride Production Growth Rate 2014-2019
6.5.2 China Ondansetron Hydrochloride Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Ondansetron Hydrochloride Import & Export
6.6 Japan
6.6.1 Japan Ondansetron Hydrochloride Production Growth Rate 2014-2019
6.6.2 Japan Ondansetron Hydrochloride Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Ondansetron Hydrochloride Import & Export

7 Ondansetron Hydrochloride Consumption by Regions
7.1 Global Ondansetron Hydrochloride Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Ondansetron Hydrochloride Consumption by Type
7.2.2 North America Ondansetron Hydrochloride Consumption by Application
7.2.3 North America Ondansetron Hydrochloride Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Ondansetron Hydrochloride Consumption by Type
7.3.2 Europe Ondansetron Hydrochloride Consumption by Application
7.3.3 Europe Ondansetron Hydrochloride Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Ondansetron Hydrochloride Consumption by Type
7.4.2 Asia Pacific Ondansetron Hydrochloride Consumption by Application
7.4.3 Asia Pacific Ondansetron Hydrochloride Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Ondansetron Hydrochloride Consumption by Type
7.5.2 Central & South America Ondansetron Hydrochloride Consumption by Application
7.5.3 Central & South America Ondansetron Hydrochloride Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Ondansetron Hydrochloride Consumption by Type
7.6.2 Middle East and Africa Ondansetron Hydrochloride Consumption by Application
7.6.3 Central & South America Ondansetron Hydrochloride Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 Inke APIs
8.1.1 Inke APIs Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Ondansetron Hydrochloride
8.1.4 Ondansetron Hydrochloride Product Introduction
8.1.5 Inke APIs Recent Development
8.2 Beaukev
8.2.1 Beaukev Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Ondansetron Hydrochloride
8.2.4 Ondansetron Hydrochloride Product Introduction
8.2.5 Beaukev Recent Development
8.3 Cadila Pharmaceutical
8.3.1 Cadila Pharmaceutical Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Ondansetron Hydrochloride
8.3.4 Ondansetron Hydrochloride Product Introduction
8.3.5 Cadila Pharmaceutical Recent Development
8.4 Cambrex
8.4.1 Cambrex Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Ondansetron Hydrochloride
8.4.4 Ondansetron Hydrochloride Product Introduction
8.4.5 Cambrex Recent Development
8.5 Dr. Reddy’s
8.5.1 Dr. Reddy’s Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Ondansetron Hydrochloride
8.5.4 Ondansetron Hydrochloride Product Introduction
8.5.5 Dr. Reddy’s Recent Development
8.6 Tapi Teva
8.6.1 Tapi Teva Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Ondansetron Hydrochloride
8.6.4 Ondansetron Hydrochloride Product Introduction
8.6.5 Tapi Teva Recent Development
8.7 SMS Pharmaceuticals
8.7.1 SMS Pharmaceuticals Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Ondansetron Hydrochloride
8.7.4 Ondansetron Hydrochloride Product Introduction
8.7.5 SMS Pharmaceuticals Recent Development
8.8 Smaart Pharmaceutical
8.8.1 Smaart Pharmaceutical Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Ondansetron Hydrochloride
8.8.4 Ondansetron Hydrochloride Product Introduction
8.8.5 Smaart Pharmaceutical Recent Development
8.9 Changzhou Kangyun Jingxi Chemical
8.9.1 Changzhou Kangyun Jingxi Chemical Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Ondansetron Hydrochloride
8.9.4 Ondansetron Hydrochloride Product Introduction
8.9.5 Changzhou Kangyun Jingxi Chemical Recent Development
8.10 Sinopharm Chuankang Pharmaceutical
8.10.1 Sinopharm Chuankang Pharmaceutical Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Ondansetron Hydrochloride
8.10.4 Ondansetron Hydrochloride Product Introduction
8.10.5 Sinopharm Chuankang Pharmaceutical Recent Development
8.11 Qilu Pharmaceutical

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Ondansetron Hydrochloride Capacity, Production Forecast 2019-2025
9.1.2 Global Ondansetron Hydrochloride Production Value Forecast 2019-2025
9.2 Ondansetron Hydrochloride Production and Production Value Forecast by Regions
9.2.1 Global Ondansetron Hydrochloride Production Value Forecast by Regions
9.2.2 Global Ondansetron Hydrochloride Production Forecast by Regions
9.3 Ondansetron Hydrochloride Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Ondansetron Hydrochloride Production Forecast by Type
9.4.2 Global Ondansetron Hydrochloride Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Ondansetron Hydrochloride Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Ondansetron Hydrochloride Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Ondansetron Hydrochloride Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Ondansetron Hydrochloride Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Ondansetron Hydrochloride Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Ondansetron Hydrochloride Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Ondansetron Hydrochloride Sales Channels
11.2.2 Ondansetron Hydrochloride Distributors
11.3 Ondansetron Hydrochloride Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Inke APIs、Beaukev、Cadila Pharmaceutical、Cambrex、Dr. Reddy’s、Tapi Teva、SMS Pharmaceuticals、Smaart Pharmaceutical、Changzhou Kangyun Jingxi Chemical、Sinopharm Chuankang Pharmaceutical、Qilu Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオンダンセトロン塩酸塩産業:成長傾向・競合分析2019-2025(Global Ondansetron Hydrochloride Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。